Incannex Healthcare Inc ADR (IXHL)

$1.05 -0.58 (-35.58%)
Market Cap 30.91M
Revenue (ttm) 10,000.00
Net Income (ttm) -18.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -184,600.00%
Debt to Equity Ratio 3.89
Volume 222,648,703
Avg Vol 135,922,094
Day's Range N/A - N/A
Shares Out 29.43M
Stochastic %K 57%
Beta 7.47
Analysts Strong Buy
Price Target N/A

Company Profile

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that has completed Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 61 4 0984 0786
Address:
8 Century Circuit, Suite 105 Norwest, Sydney, Australia
JackB2025
JackB2025 Jul. 27 at 5:23 AM
$IXHL Hotcopper post, so true!
1 · Reply
BigPablo2025
BigPablo2025 Jul. 27 at 5:18 AM
$IXHL everyone wants 5 or $10.... hell I'll sell for 2.20 for 100% daily gain.
2 · Reply
Zukarude
Zukarude Jul. 27 at 5:16 AM
$IXHL nothing should be boring next week
0 · Reply
insomniaAU
insomniaAU Jul. 27 at 5:14 AM
$IXHL what are you expecting on monday guys?
1 · Reply
Anbat3552
Anbat3552 Jul. 27 at 5:12 AM
$IXHL so boring . Everyone is sleeping , market is closed. See you Sunday after hours. This week news is coming
0 · Reply
Sharmaaa
Sharmaaa Jul. 27 at 5:10 AM
$IXHL
1 · Reply
GfromTn
GfromTn Jul. 27 at 5:00 AM
$IXHL if @Stocktwits trended $OPEN under $5 why is this not trending… I searched and it says there is no price criteria to trending… Is that true or false? If so either way please explain your policy on trending
0 · Reply
NobodyCaresEither
NobodyCaresEither Jul. 27 at 4:59 AM
$IXHL my dogs will finally get their raw prime rib they have demanded.
1 · Reply
richkid_26
richkid_26 Jul. 27 at 4:54 AM
$IXHL a run-up tom night to $2-3 would be nice
0 · Reply
Therealfreeze
Therealfreeze Jul. 27 at 4:50 AM
$IXHL My thoughts…… Resmed will buy or partner the OSA program, not the company adding massive share price value. The company will then be open to continue to add value by progressing arthritis and Psychadelics programs. Both of which are very promising in their own right.
1 · Reply
Latest News on IXHL
Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Jul 25, 2025, 7:30 AM EDT - 1 day ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Jun 24, 2025, 7:30 AM EDT - 4 weeks ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Jun 18, 2025, 7:30 AM EDT - 5 weeks ago

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Jun 17, 2025, 7:30 AM EDT - 5 weeks ago

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Jun 12, 2025, 7:30 AM EDT - 6 weeks ago

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Jun 3, 2025, 7:30 AM EDT - 7 weeks ago

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

May 29, 2025, 7:30 AM EDT - 2 months ago

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025

May 28, 2025, 4:21 PM EDT - 2 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

May 28, 2025, 7:00 AM EDT - 2 months ago

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

May 20, 2025, 7:30 AM EDT - 2 months ago

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

May 16, 2025, 9:00 AM EDT - 2 months ago

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

May 15, 2025, 8:00 AM EDT - 2 months ago

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?

May 14, 2025, 4:14 PM EDT - 2 months ago

Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

May 14, 2025, 8:00 AM EDT - 2 months ago

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Apr 3, 2025, 7:30 AM EDT - 4 months ago

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Mar 7, 2025, 2:10 PM EST - 5 months ago

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Feb 18, 2025, 5:51 PM EST - 5 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Feb 14, 2025, 7:30 AM EST - 5 months ago

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Feb 4, 2025, 9:15 AM EST - 6 months ago

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Jan 23, 2025, 7:30 AM EST - 6 months ago

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Dec 2, 2024, 4:48 PM EST - 8 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

Nov 14, 2024, 4:05 PM EST - 9 months ago

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

Oct 24, 2024, 7:30 AM EDT - 9 months ago

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Oct 2, 2024, 4:50 PM EDT - 10 months ago

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

Sep 30, 2024, 4:01 PM EDT - 10 months ago

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

Sep 9, 2024, 8:00 AM EDT - 11 months ago

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

Aug 5, 2024, 7:30 AM EDT - 1 year ago

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X

Jul 30, 2024, 7:30 AM EDT - 1 year ago

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

May 30, 2024, 7:30 AM EDT - 1 year ago

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder

May 7, 2024, 7:30 AM EDT - 1 year ago

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder

Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)

May 1, 2024, 2:33 PM EDT - 1 year ago

Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

Feb 16, 2024, 7:30 AM EST - 1 year ago

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

Clarion Clinics Open for Psychedelic-Assisted Treatments

Feb 1, 2024, 7:30 AM EST - 1 year ago

Clarion Clinics Open for Psychedelic-Assisted Treatments

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Jan 24, 2024, 4:05 PM EST - 1 year ago

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

Jan 18, 2024, 8:22 AM EST - 1 year ago

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Jan 17, 2024, 7:30 AM EST - 1 year ago

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

Dec 21, 2023, 4:05 PM EST - 1 year ago

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

Dec 6, 2023, 7:30 AM EST - 1 year ago

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

Incannex Healthcare Announces Completion of its Redomiciliation to the United States

Nov 29, 2023, 1:40 PM EST - 1 year ago

Incannex Healthcare Announces Completion of its Redomiciliation to the United States

Federal Court of Australia Approves Incannex's Re-Domiciliation and Lodgement of Court Orders With ASIC

Nov 16, 2023, 8:30 AM EST - 1 year ago

Federal Court of Australia Approves Incannex's Re-Domiciliation and Lodgement of Court Orders With ASIC

Incannex Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference - September 11-13, 2023

Sep 8, 2023, 7:30 AM EDT - 2 years ago

Incannex Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference - September 11-13, 2023

Incannex to Prepare FDA IND Application for Psilocybin-assisted Psychedelic Psychotherapy Program, Known as Psi-GAD

Aug 24, 2023, 7:30 AM EDT - 2 years ago

Incannex to Prepare FDA IND Application for Psilocybin-assisted Psychedelic Psychotherapy Program, Known as Psi-GAD

Review of IND Application for IHL-42X by US FDA has been completed; Clinical Trial for Patients with Obstructive Sleep Apnoea May Proceed

Aug 22, 2023, 7:30 AM EDT - 2 years ago

Review of IND Application for IHL-42X by US FDA has been completed; Clinical Trial for Patients with Obstructive Sleep Apnoea May Proceed

Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening

Aug 8, 2023, 8:00 AM EDT - 2 years ago

Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

Jul 28, 2023, 7:30 AM EDT - 2 years ago

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis

Jul 26, 2023, 7:30 AM EDT - 2 years ago

Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis

Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea

Jul 21, 2023, 9:09 AM EDT - 2 years ago

Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea

Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep Apnoea

Jul 18, 2023, 7:40 AM EDT - 2 years ago

Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep Apnoea

Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq

Jul 10, 2023, 7:30 AM EDT - 2 years ago

Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq

Incannex Receives Ethics Approval for Bioequivalence/Bioavailability Clinical Trial for IHL-42X, the Company's Proprietary Drug for Treatment of Obstructive Sleep Apnoea (‘OSA')

Jul 6, 2023, 8:42 AM EDT - 2 years ago

Incannex Receives Ethics Approval for Bioequivalence/Bioavailability Clinical Trial for IHL-42X, the Company's Proprietary Drug for Treatment of Obstructive Sleep Apnoea (‘OSA')

JackB2025
JackB2025 Jul. 27 at 5:23 AM
$IXHL Hotcopper post, so true!
1 · Reply
BigPablo2025
BigPablo2025 Jul. 27 at 5:18 AM
$IXHL everyone wants 5 or $10.... hell I'll sell for 2.20 for 100% daily gain.
2 · Reply
Zukarude
Zukarude Jul. 27 at 5:16 AM
$IXHL nothing should be boring next week
0 · Reply
insomniaAU
insomniaAU Jul. 27 at 5:14 AM
$IXHL what are you expecting on monday guys?
1 · Reply
Anbat3552
Anbat3552 Jul. 27 at 5:12 AM
$IXHL so boring . Everyone is sleeping , market is closed. See you Sunday after hours. This week news is coming
0 · Reply
Sharmaaa
Sharmaaa Jul. 27 at 5:10 AM
$IXHL
1 · Reply
GfromTn
GfromTn Jul. 27 at 5:00 AM
$IXHL if @Stocktwits trended $OPEN under $5 why is this not trending… I searched and it says there is no price criteria to trending… Is that true or false? If so either way please explain your policy on trending
0 · Reply
NobodyCaresEither
NobodyCaresEither Jul. 27 at 4:59 AM
$IXHL my dogs will finally get their raw prime rib they have demanded.
1 · Reply
richkid_26
richkid_26 Jul. 27 at 4:54 AM
$IXHL a run-up tom night to $2-3 would be nice
0 · Reply
Therealfreeze
Therealfreeze Jul. 27 at 4:50 AM
$IXHL My thoughts…… Resmed will buy or partner the OSA program, not the company adding massive share price value. The company will then be open to continue to add value by progressing arthritis and Psychadelics programs. Both of which are very promising in their own right.
1 · Reply
PennyStockRaider1
PennyStockRaider1 Jul. 27 at 4:49 AM
$IXHL Yes this was my earlier post. Why would they delay the Phase 2 news until the literal last week of July? And we have resmed on incannex board
0 · Reply
ms2400
ms2400 Jul. 27 at 4:43 AM
$IXHL strongest indication of partnership at minimum is the advisory share
0 · Reply
NovaDog697
NovaDog697 Jul. 27 at 4:21 AM
$IXHL Splits... Yes, Incannex Healthcare (IXHL) has had a stock split. Specifically, it underwent a reverse stock split with a ratio of 1:4 on November 30, 2023 So 360/4=$90.00... buyout Partnership and Time ... =🧐💲
1 · Reply
ms2400
ms2400 Jul. 27 at 4:20 AM
$IXHL breakout over $5 will fuel a $50 rally imo this week ive seen it happen many times
4 · Reply
tiburon1983
tiburon1983 Jul. 27 at 4:18 AM
$IXHL
1 · Reply
Spc_baller
Spc_baller Jul. 27 at 4:18 AM
$IXHL BUY OUT WOULD BE NICE
0 · Reply
Spc_baller
Spc_baller Jul. 27 at 4:17 AM
$IXHL
0 · Reply
ThrawnVestor
ThrawnVestor Jul. 27 at 4:16 AM
$IXHL taxes 🥹😭
1 · Reply
P3anutButt3r
P3anutButt3r Jul. 27 at 4:14 AM
$RMD $IXHL Article posted today stating there are whispers there could be a buyout. https://www.acrossmarkets.icu/2025/07/wall-street-whispers-is-resmed-eyeing.html?m=1
0 · Reply
NovaDog697
NovaDog697 Jul. 27 at 4:12 AM
$IXHL Get that Money/Gains
2 · Reply
ms2400
ms2400 Jul. 27 at 4:12 AM
$IXHL if it starts moving hot tomorrow night buckle in for a real hot jump over $2 and $3 before data release
0 · Reply
P3anutButt3r
P3anutButt3r Jul. 27 at 4:09 AM
$IXHL Wow, we almost have 10k on the watchlist to see is $RMD makes an offer. First row seats
0 · Reply